A Double-Blind, Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in Adult Outpatients With Generalized Social Anxiety Disorder
@article{Rickels2004ADP, title={A Double-Blind, Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in Adult Outpatients With Generalized Social Anxiety Disorder}, author={K. Rickels and R. Mangano and A. Khan}, journal={Journal of Clinical Psychopharmacology}, year={2004}, volume={24}, pages={488-496} }
Abstract: Venlafaxine extended release (ER) is a dual serotonin-norepinephrine reuptake inhibitor previously shown to be effective in the treatment of major depressive disorder and generalized anxiety disorder. This placebo-controlled, multicenter, randomized, double-blind trial examined the efficacy and safety of venlafaxine ER in outpatients with generalized social anxiety disorder. Two hundred seventy-two outpatients were randomly assigned to receive either a flexible dose of venlafaxine ER… Expand
Topics from this paper
Paper Mentions
Interventional Clinical Trial
Previous studies have demonstrated that venlafaxine significantly improves the language
function of healthy subjects and increase of fMRI activation in cortical language area. This… Expand
Conditions | Ischemic Stroke, Subcortical Aphasia |
---|---|
Intervention | Drug |
87 Citations
A double‐blind study of the efficacy of venlafaxine extended‐release, paroxetine, and placebo in the treatment of panic disorder
- Psychology, Medicine
- Depression and anxiety
- 2007
- 87
A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder
- Medicine
- Psychopharmacology
- 2007
- 23
A Randomized Controlled Trial of Venlafaxine ER Versus Placebo in Pediatric Social Anxiety Disorder
- Psychology, Medicine
- Biological Psychiatry
- 2007
- 119
A Multicenter, Placebo‐Controlled, Double‐Blind, Randomized Study of Efficacy and Safety of Ocinaplon (DOV 273,547) in Generalized Anxiety Disorder
- Psychology, Medicine
- CNS neuroscience & therapeutics
- 2010
- 23
Long-term efficacy of pregabalin in generalized anxiety disorder
- Psychology, Medicine
- International clinical psychopharmacology
- 2008
- 108
Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study
- Psychology, Medicine
- Depression and anxiety
- 2005
- 68
Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials
- Psychology, Medicine
- Psychopharmacology
- 2010
- 20
- Highly Influenced
SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants
- Medicine
- CNS Spectrums
- 2005
- 404
Mirtazapine Treatment of Social Phobia in Women: A Randomized, Double-Blind, Placebo-Controlled Study
- Medicine, Psychology
- Journal of clinical psychopharmacology
- 2005
- 60
References
SHOWING 1-10 OF 51 REFERENCES
A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.
- Medicine, Psychology
- Journal of affective disorders
- 1999
- 154
Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
- Psychology, Medicine
- The Journal of clinical psychiatry
- 1999
- 219
Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group.
- Medicine
- The Journal of clinical psychiatry
- 1997
- 31
The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group.
- Psychology, Medicine
- Journal of clinical psychopharmacology
- 1998
- 84
Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
- Psychology, Medicine
- The Journal of clinical psychiatry
- 2001
- 228
Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
- Medicine
- JAMA
- 2000
- 264
- PDF
Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients.
- Medicine, Psychology
- Journal of affective disorders
- 1998
- 58
Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment.
- Psychology, Medicine
- Journal of clinical psychopharmacology
- 2000
- 77
Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
- Psychology, Medicine
- The American journal of psychiatry
- 2001
- 200
Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
- Psychology, Medicine
- The Journal of clinical psychiatry
- 1999
- 248